COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery (PSMA vs AXUMIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03515577
Recruitment Status : Completed
First Posted : May 3, 2018
Last Update Posted : July 24, 2020
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 25, 2019
Actual Study Completion Date : April 25, 2019